PI
EBS icon

PineBridge Investments’s Emergent Biosolutions EBS Stock Holding History

PineBridge Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-21,427
Closed -$1.16M – 840
2019
Q4 		$1.16M Sell
21,427
-16,661
-44% -$904K 0.02% 531
2019
Q3 		$1.99M Buy
38,088
+1,490
+4% +$69.4K 0.03% 401
2019
Q2 		$1.77M Buy
36,598
+6,595
+22% +$316K 0.03% 401
2019
Q1 		$1.52M Buy
30,003
+19,263
+179% +$1.14M 0.03% 417
2018
Q4 		$637K Buy
10,740
+1,593
+17% +$103K 0.01% 626
2018
Q3 		$603K Buy
9,147
+2,874
+46% +$168K 0.01% 703
2018
Q2 		$317K Sell
6,273
-203
-3% -$10.6K 0.01% 776
2018
Q1 		$341K Sell
6,476
-35,678
-85% -$1.78M 0.01% 761
2017
Q4 		$1.96M Buy
42,154
+10,460
+33% +$440K 0.05% 366
2017
Q3 		$1.28M Sell
31,694
-86
-0.3% -$3.11K 0.03% 464
2017
Q2 		$1.08M Buy
31,780
+27,268
+604% +$842K 0.03% 478
2017
Q1 		$131K Buy
4,512
+140
+3% +$4.26K ﹤0.01% 873
2016
Q4 		$144K Hold
4,372
– – ﹤0.01% 902
2016
Q3 		$138K Buy
4,372
+408
+10% +$11.9K 0.01% 656
2016
Q2 		$112K Buy
3,964
+202
+5% +$7.92K 0.01% 722
2016
Q1 		$137K Sell
3,762
-315
-8% -$11.1K 0.01% 614
2015
Q4 		$163K Buy
4,077
+292
+8% +$10.2K 0.01% 589
2015
Q3 		$108K Buy
3,785
+354
+10% +$11.7K ﹤0.01% 738
2015
Q2 		$113K Sell
3,431
-4,203
-55% -$130K ﹤0.01% 714
2015
Q1 		$219K Buy
7,634
+1,082
+17% +$31K 0.01% 710
2014
Q4 		$178K Buy
6,552
+281
+4% +$6.7K 0.01% 750
2014
Q3 		$133K Buy
6,271
+1,745
+39% +$40K 0.01% 778
2014
Q2 		$102K Sell
4,526
-2,792
-38% -$65K ﹤0.01% 772
2014
Q1 		$185K Sell
7,318
-329
-4% -$8.31K 0.01% 786
2013
Q4 		$176K Buy
7,647
+4,381
+134% +$91.3K 0.01% 824
2013
Q3 		$62K Buy
3,266
+388
+13% +$6.93K ﹤0.01% 871
2013
Q2 		$41K Buy
+2,878
New +$41.7K ﹤0.01% 970

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PineBridge Investments's EBS Position: Q1 2020 in Review

PineBridge Investments sold out of Emergent Biosolutions (EBS) in Q1 2020, closing a stake of 21,427 shares — an estimated $1.16M sold.

PineBridge Investments first reported a position in EBS in Q2 2013 and held it in 27 quarters. The position peaked at $1.99M in Q3 2019. 261 funds tracked by Wall St. Rank hold EBS as of Q1 2020.

  • PineBridge Investments reported no remaining Emergent Biosolutions position as of Q1 2020 after selling out during the quarter.
  • PineBridge Investments sold 21,427 Emergent Biosolutions shares in Q1 2020, an estimated $1.16M.
  • PineBridge Investments first reported a position in Emergent Biosolutions in Q2 2013 and held it in 27 quarters.
  • PineBridge Investments's Emergent Biosolutions position peaked at $1.99M in Q3 2019.
  • 261 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2020.

Based on PineBridge Investments's 13F filing for Q1 2020, filed 14 May 2020.